Advanced Science · 15 Nov 2026
Tolerogenic Immunotherapy for Type 1 Diabetes Through Sustained Autoantigen Delivery in a Transient Inflammatory Niche
Leslee T. Nguyen, Ye Eun Song, Andrea I. d'Aquino, Jerry Yan, Anahita Nejatfard, Kyra Gillard, Vanessa Doulames, Priya Ganesh, Ben S. Ou, Olivia M. Saouaf, Tatum Wilhelm, Sophia Bailey, Katie Lu, Noah Eckman, Saira Reyes, Daniel R. Mejia, Eric A. Appelh-index 53
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
ABSTRACT Type 1 diabetes (T1D) is a T‐cell‐mediated autoimmune disease characterized by destruction of pancreatic β‐cells, resulting in lifelong insulin therapy dependence and risk of severe complications. Tolerogenic immunotherapies offer a promising strategy to restore antigen‐specific immune tolerance and prevent T1D but have been limited by challenges in controlled spatiotemporal exposure of antigens and immunomodulators to achieve robust tolerance. Here, we report the development of injectable hydrogel depot formulations providing sustained co‐delivery of insulin autoantigen and low‐dose interleukin‐2 (IL‐2) and which form transient tolerogenic niches following subcutaneous administration. These treatments recruit and expand regulatory T cells both within the hydrogel niche and draining lymph nodes, inducing tolerance responses in the spleen and pancreas and increasing the median time to diabetes onset in non‐obese diabetic mice from 20 to >40 weeks. These studies suggest that sustained co‐exposure of autoantigen in the appropriate immune environment can promote durable tolerance for T1D prevention.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Eric A. Appel has the highest h-index among the authors (53).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (62)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 42 more references
A free account opens the rest of the citing papers and references on every paper’s page.